Differing Associations between Fatty Liver and Dyslipidemia According to the Degree of Hepatic Steatosis in Korea
10.12997/jla.2019.8.2.258
- Author:
Ji Min HAN
1
;
Hye In KIM
;
Yu Ji LEE
;
Jung Won LEE
;
Kwang Min KIM
;
Ji Cheol BAE
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. drkuri10@skku.edu
- Publication Type:Original Article
- Keywords:
Fatty liver;
Dyslipidemias;
Tomography, spiral computed
- MeSH:
Blood Glucose;
Body Mass Index;
Cholesterol;
Delivery of Health Care;
Dyslipidemias;
Fasting;
Fatty Liver;
Glucose;
Gyeongsangnam-do;
Hemoglobin A, Glycosylated;
Humans;
Insulin;
Korea;
Lipoproteins;
Liver;
Male;
Obesity;
Odds Ratio;
Tomography, Spiral Computed;
Triglycerides
- From:Journal of Lipid and Atherosclerosis
2019;8(2):258-266
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Fatty liver is associated with insulin resistance-related diseases, such as dyslipidemia, obesity, and type 2 diabetes. The aim of this study was to evaluate the association of dyslipidemia with fatty liver and assess the differences in these associations according to the degree of hepatic steatosis. METHODS: A total of 2,462 subjects (1,679 men and 783 women) who underwent a comprehensive health check-up (including abdominal computed tomography) from January 2010 to December 2013 were enrolled at Samsung Changwon Hospital Healthcare Center. The liver attenuation index (LAI), defined as the difference between mean hepatic and splenic attenuation, was used to assess the degree of hepatic steatosis. An LAI below 5 Hounsfield units was defined as fatty liver. RESULTS: We found that 32.2% of the study subjects had fatty liver. Serum low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG), and fasting blood glucose concentrations and glycated hemoglobin (HbA1c percentage) were significant greater in the fatty liver group compared with the non-fatty liver group, while serum high-density lipoprotein cholesterol (HDL-C) was significantly lower in the fatty liver group. Subjects with fatty liver had 1.7-fold greater risk of dyslipidemia than those without fatty liver after adjusting for age, sex, body mass index (BMI), and HbA1c. When individuals with fatty liver were analyzed by tertiles of LAI values, LDL-C, TG, fasting glucose, BMI, and HbA1c concentrations increased while HDL-C decreased with decreasing LAI tertiles. Compared with LAI tertile 3, the risk for dyslipidemia significantly increased with adjusted odds ratios of 1.42, and 1.81 in tertiles 2 and 1, respectively. CONCLUSION: Fatty liver was significantly associated with dyslipidemia and this association varied according to the degree of hepatic steatosis.
